PERIPHERAL & CENTRAL NERVOUS SYSTEM DRUGS ADVISORY COMMITTEE

March 13, 2001

Slides

Mild Cognitive Impairment: Unresolved Issues, Ronald C Petersen, Mayo Clinic  ppt   html

MCI Conversion to Dementia:  Clinc and Community-Based Studies, Ranjan Duara, MD, Wien Center for Alzheimer's Disease & Memory Disorders   ppt   html

Mild Cognitive Impairment as a Target for Drug Development, Steven H Ferris PhD, Silbertstein Aging and Dementia Research Center   ppt   html

Defining Mild Cognitive Impairment, Steven T DeKosky, MD, Alzheimer's Disease Research Center   ppt   html

Mild Cognitive Impairment: A View from the Trenches, Mary Ganguli    ppt   html

MCI Clinical Trial Design, Michael Grundman, MD, MPH, Alzheimer's Disease Cooperative Study   ppt   html

Barry Reisbert, MD, International Psychogeriatric Association   ppt  html

Tony Waegemans, MD, UCB Pharma   ppt  html

Speed of processing, the missing measure in early detection of MCI?  Yogesh Shah, Ruth O'Hara   ppt   html